GlassScriptPhysician profile
Kaitlyn Mayer
NPI 1972961191
$596.07
in general payments reported to CMS, 2019-2025
14 companies · $460 in 2025
The $460 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $136 · 2025: $460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $596.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $596.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $75.38 | 2024-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $69.31 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Acessa Provu System |
| Smith+Nephew, INC. | $59.68 | 2025 | Pico |
| Astellas Pharma US INC | $52.13 | 2024-2025 | Veozah |
| Mayne Pharma Commercial LLC | $51.06 | 2025 | |
| Millicent US INC | $46.27 | 2024-2025 | Intrarosa, Femlyv, Femring |
| Sumitomo Pharma America, INC. | $44.44 | 2025 | Myfembree |
| Exeltis, USA INC. | $41.63 | 2024-2025 | Slynd |
| Daiichi Sankyo INC. | $40.54 | 2025 | Injectafer |
| Biogen, INC. | $37.28 | 2024-2025 | Zurzuvae |
| Aspira Women'S Health INC | $25.64 | 2024 | Ova1 |
| Bayer Healthcare Pharmaceuticals INC. | $19.50 | 2025 | |
| Minerva Surgical, INC | $16.64 | 2025 | |
| Pfizer INC. | $16.57 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaitlyn Mayer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.